CURE vs. GBTC
CURE (Direxion Daily Healthcare Bull 3x Shares) and GBTC (Grayscale Bitcoin Trust ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while GBTC is a Cryptocurrency fund tracking the CoinDesk Bitcoin Benchmark Rate Index. Both are passively managed. Over the past 10 years, CURE returned 13.02%/yr vs 49.25%/yr for GBTC. At a 0.13 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 1.50%/yr for GBTC.
Performance
CURE vs. GBTC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -9.94% return, which is significantly higher than GBTC's -28.07% return. Over the past 10 years, CURE has underperformed GBTC with an annualized return of 13.02%, while GBTC has yielded a comparatively higher 49.25% annualized return.
CURE
- 1D
- -0.69%
- 1M
- 18.27%
- YTD
- -9.94%
- 6M
- -3.58%
- 1Y
- 30.33%
- 3Y*
- 3.28%
- 5Y*
- 1.60%
- 10Y*
- 13.02%
GBTC
- 1D
- 5.06%
- 1M
- -21.09%
- YTD
- -28.07%
- 6M
- -30.74%
- 1Y
- -40.20%
- 3Y*
- 53.71%
- 5Y*
- 10.31%
- 10Y*
- 49.25%
CURE vs. GBTC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -9.94% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
GBTC Grayscale Bitcoin Trust ETF | -28.07% | -7.65% | 113.81% | 317.61% | -75.80% | 7.03% | 290.72% | 106.56% | -82.10% | 1,787.72% |
Correlation
The correlation between CURE and GBTC is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since May 5, 2015 | 0.13 |
The correlation between CURE and GBTC shifts across timeframes, from 0.08 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. GBTC — Risk / Return Rank
CURE
GBTC
CURE vs. GBTC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Grayscale Bitcoin Trust ETF (GBTC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE | GBTC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.61 | ||
| Sortino ratioReturn per unit of downside risk | +2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.86 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 0.98 | -0.77 | +1.75 |
| Martin ratioReturn relative to average drawdown | 2.24 | -1.38 | +3.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE | GBTC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.69 | -0.91 | +1.61 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | 0.17 | -0.13 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | 0.60 | -0.34 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.65 | -0.18 |
Drawdowns
CURE vs. GBTC - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum GBTC drawdown of -89.91%. Use the drawdown chart below to compare losses from any high point for CURE and GBTC.
Loading charts...
Drawdown Indicators
| CURE | GBTC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -89.91% | +20.72% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -52.45% | +21.35% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -52.45% | +0.52% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -85.42% | +33.19% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -89.91% | +20.72% |
Current DrawdownCurrent decline from peak | -28.51% | -50.05% | +21.54% |
Average DrawdownAverage peak-to-trough decline | -18.15% | -43.44% | +25.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.57% | 29.16% | -15.59% |
Volatility
CURE vs. GBTC - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.68% compared to Grayscale Bitcoin Trust ETF (GBTC) at 11.75%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than GBTC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | GBTC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.68% | 11.75% | +2.93% |
Volatility (6M)Calculated over the trailing 6-month period | 31.01% | 34.55% | -3.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.18% | 44.19% | -0.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.88% | 62.40% | -18.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.60% | 82.22% | -32.62% |
CURE vs. GBTC - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is lower than GBTC's 1.50% expense ratio.
Dividends
CURE vs. GBTC - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.18%, while GBTC has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.18% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
GBTC Grayscale Bitcoin Trust ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.61% |
Frequently Asked Questions
CURE and GBTC have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.68%) compared to GBTC (11.75%). In terms of maximum drawdown, CURE dropped -69.19% vs GBTC's -89.91%.
On 10-year performance, GBTC leads with 49.25% vs 13.02% for CURE. On fees, CURE is cheaper at 1.08% per year. On volatility, GBTC has been the lower-risk option at 11.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, GBTC has performed better with a 49.25% return vs 13.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 1.08% expense ratio, compared with 1.50% for GBTC.
CURE has the higher dividend yield at 1.18%, compared with 0.00% for GBTC.
CURE is categorized as Leveraged Equities, while GBTC is Cryptocurrency. CURE tracks Health Care Select Sector Index (300%), while GBTC tracks CoinDesk Bitcoin Benchmark Rate Index. They also come from different issuers: Direxion and Grayscale. Their fees differ too: 1.08% for CURE and 1.50% for GBTC.
CURE currently has the higher Sharpe Ratio (0.69 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and GBTC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer